常茂生物(00954.HK)擬在大連長興島收購土地建造工廠 預計總投資7億元
格隆匯 12 月 2日丨常茂生物(00954.HK)發佈公告,公司與大連長興島經濟區管理委員會於2020年12月2日訂立了投資合同。公司同意在該土地上建造工廠,建設項目包括年產4萬噸順酐、年產5噸PQQ.Na2、油品助劑的生產線和手性藥物中間體的研發及中試生產線項目等(具體以最終立項備案文件為準)。預計總投資額人民幣7億元,其中固定資產投資人民幣5.88億元。簽訂該土地的《國有土地使用權出讓合同》後3個月內開工建設,24個月內竣工並投產。上述建設項目取決於公司是否成功競買該土地。
公司將通過新成立的全資附屬公司,通過“招標、拍賣和掛牌”程序競買土地,該土地位於遼寧省大連市長興島,屬工業用地,總面積約為18.9萬平方米。該土地的使用期限為50年。該土地的競買底價為每平方米人民幣380元。
公告稱,因近期政府政策變更,公司須將其位於常州市濱江區部份工廠生產設施及辦公樓搬遷。因此,公司訂立有關收購土地的投資合同,目的是搬遷其位於常州市濱江區原生產工廠的部份生產線至該土地的所在地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.